Core Laboratories (NYSE: CLB) reported Q4 EPS of $0.41, in-line with the analyst estimate of $0.41. Revenue for the quarter came in at $149.5 million versus the consensus estimate of $145.78 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.